Bio-Techne invests in China-based cell and gene therapy media company

By The Science Advisory Board staff writers

January 28, 2021 -- Bio-Techne has made an initial minority strategic equity investment in Changzhou Eminence Biotechnology (Eminence). The companies will synergistically work on the development and commercialization of good manufacturing practice (GMP) molecules and proteins for cell and gene therapy media.

Eminence will use the funds to expand its manufacturing capacity and increase the service capabilities of its China-headquartered GMP media production facility. Eminence will leverage Bio-Techne's industry-wide recognition as a high-quality supplier to the life sciences industry and its existing relationships with biopharmaceutical companies.

Founded in 2016, Eminence is focused on supplying life science companies with media, including Chinese hamster ovary (CHO) cells and other serum-free media products, as well as custom cell line and media formulation development services. The company is in the process of completing and scaling its GMP production facility, which is expected to be finished by the end of 2021.

ScaleReady launches to improve T-cell manufacturing
A new joint venture called ScaleReady has been launched to develop tools and technologies for use in cell and gene therapy manufacturing. The firm is...
Bio-Techne opens GMP manufacturing facility
Bio-Techne has opened a 61,000-sq-ft good manufacturing practice (GMP) manufacturing facility in St. Paul, MN. The space will be dedicated to large-scale...
Bio-Techne rebrands genome engineering as part of R&D Systems portfolio
Bio-Techne has rebranded its cell and gene engineering product offer as part of its R&D Systems biotechnology brand.
Bio-Techne releases product for manufacturing
Bio-Techne has released GMP ProDots Proteins to support cell and gene therapy manufacturing workflows. The product will allow manufacturers to safely...
Joint venture targets cell and gene therapy
A new joint venture dedicated to supporting researchers and biopharmaceutical companies in cell and gene therapy was announced on January 21. The joint...

Copyright © 2021 scienceboard.net


Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter